Palvella Therapeutics, Inc. Files Form 8-K with SEC – Company Details, Address, and Stock Information (NASDAQ: PVLA) 161851
Palvella Therapeutics, Inc. Announces Uplisting to Nasdaq Gl...
Sign in to continue:
Palvella Therapeutics, Inc. Announces Uplisting to Nasdaq Gl...
MIRA Pharmaceuticals, Inc. Announces Peer-Reviewed Publicati...
Abeona Therapeutics Reports Q1 2026 Results and Strategic Pi...
Vishay Intertechnology Reports Q1 2026 Results: Key Highligh...
Arbutus Biopharma Corporation Reports Q1 2026 Financial Resu...
Rent the Runway CEO Transition and Strategic Update: What In...
Altimmune Q1 2026 Financial Results and Business Update: Det...
Local Bounti Corporation Reports Q1 2026 Results: Key Highli...
Future Vision II Acquisition Corp. - Material Event Report (...
Ironwood Pharmaceuticals, Inc. Files Form 8-K Ironwood...